Author

J.S. Graff

Observed names: J Graff, J. Graff, JS Graff

Institution: National Pharmaceutical Council

Observed institutions: Pfizer (United States), University of Michigan, National Pharmaceutical Council

OpenAlex ID: A5111920482

Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin

2006 · P. Lindgren, J. Graff, et al. · European Heart Journal · 60

Po16-439 Cost-effectiveness of Intensive Lipid-lowering Treatment in Secondary Cardiovascular Prevention in Spain and Germany

2007 · D.C.A. Taylor, A. Pandya, et al. · Atherosclerosis Supplements · 1

Mo-P5:344 Cost-effectiveness of intensive lipid-lowering treatment with atorvastatin 80MG versus 10MG in secondary cardiovascular prevention in the UK

2006 · D.C.A. Taylor, A. Pandya, et al. · Atherosclerosis Supplements · 1

Pmu52 Step Therapy as an Approach to Address Health Care Costs: Principles, Legislation and Patient Outcomes

2019 · T. Karmarkar, R.W. Dubois, et al. · Value in Health

PDF

Pns145 Patients Have Little, If Any, Input Into Commercial Health Plan Specialty Drug Coverage Policy Development

2019 · B. D'cruz, A. Panzer, et al. · Value in Health

Factors Predicting Restrictions on US Commercial Payer Coverage of Specialty Drugs

2018 · DD Kim, E Pope, et al. · Value in Health

Do Journal Editors Perceive Real-world Evidence as Valuable?

2016 · C.D. Mullins, C. Anyanwu, et al. · Value in Health

New Tools for New Challenges: Improving the Utility of Comparative Effectiveness Research in Decision Making

2016 · M.K. Pickering, E.M. Perfetto, et al. · Value in Health

Improvements in self-reported real-world decision-making ability after completion of a comparative effectiveness research continuing Education Certificate

2015 · M.K. Pickering, E.M. Perfetto, et al. · Value in Health

DR4 Clarity, Consistency and Transparency in Decision-Making: Testing a Novel P&T Framework for Assessing Evidence

2012 · J. Graff, B. Dean, et al. · Value in Health

Cv3 Cost-effectivenesss of Intensive Statin Therapy Compared to Moderate Statin Therapy in Patients With Acute Coronary Syndrome: Analysis From Canada, Germany and the Uk

2006 · MF Drummond, JS Schwartz, et al. · Value in Health

PDF

Pcv28 Cost-effectiveness of Intensive Lipid-lowering Treatment in Secondary Cardiovascular Prevention in Spain and Germany

2006 · DC Taylor, A Pandya, et al. · Value in Health

Pcv47 an Approach to Generalize Clinical Trial Results to Non-study Populations for Cost-effectiveness Evaluations—the Case of the Collaborative Atorvastatin Diabetes Study (cards)

2006 · SJ Johnson, J Graff, et al. · Value in Health

Pcv6 Impact of Statin Therapy Intensity on All-cause Mortality Following Cardiovascular Hospitalization in a Managed Care Population

2005 · DJ Fintel, A Joyce, et al. · Value in Health

Pao22 Refill Adherence in Osteoporotic Women With Primary and Secondary Fracture Prevention

2002 · CD Beilfuss, MJ Wall, et al. · Value in Health

PDF

Pao21 Missed Opportunities in Pharmaceutical Treatment of Osteoporosis in Post-fracture Women

2002 · MJ Wall, CD Beilfuss, et al. · Value in Health

Pmh13 Impact of Anxiety on Absenteeism: Estimates From the 1997 Medical Expenditure Panel Survey

2002 · JS Graff, TN Taylor, et al. · Value in Health

PDF

Pcv28: Cholesterol Reduction Success Rates and Resource Utilization by Gender

2001 · JS Graff, M Plante, et al. · Value in Health

Works count: 18

Citation count: 62

H-index: 1

I10-index: 1